Jill Marie Broadfoot - Jan 13, 2022 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Chief Financial Officer
Signature
Nancy E. Denyes, attorney-in-fact
Stock symbol
LIFE
Transactions as of
Jan 13, 2022
Transactions value $
$12,980
Form type
4
Date filed
1/18/2022, 07:39 AM
Previous filing
Nov 23, 2021
Next filing
Feb 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common stock Purchase $13K +1.92K +18.87% $6.75 12.1K Jan 13, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 178 shares acquired under the Company's 2015 Employee Stock Purchase Plan on November 15, 2021.